Bogusława Pietrzak
Medical University of Łódź
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Bogusława Pietrzak.
American Journal of Drug and Alcohol Abuse | 2015
Ewa Zwierzyńska; Agata Krupa; Bogusława Pietrzak
Abstract Background: Retigabine is a new antiepileptic drug with multiple mechanisms of action. It may well interact with ethanol, as both have an influence on GABA-ergic and glutamate neurotransmission. Objectives: To assess the effect of retigabine, administered as single or repeated doses, on ethanol-induced changes in the bioelectric activity of selected brain structures in rabbits. Methods: 30 rabbits were used to assess the effect of retigabine on ethanol-induced changes in EEGs using the pharmaco-EEG method. Retigabine was administered p.o. as a single dose (5 mg/kg or 10 mg/kg) or repeatedly at a dose of 5 mg/kg/day for 14 days. Ethanol was injected i.v. at a dose of 0.8 g/kg 60 min after the administration of retigabine. Results: Retigabine, administered as a single high or low dose, increased the depressive effect of an acute dose of ethanol on the bioelectric activity of the frontal cortex in rabbits. These changes were also visible in the recordings from the hippocampus and midbrain reticular formation after administration of a high dose of the drug. Retigabine administered in repeated doses decreased ethanol-induced changes in the rabbit EEG recordings from the hippocampus. Conclusion: Retigabine in multiple doses decreases the sensitivity of the hippocampus to an acute dose of ethanol in rabbits. Given the role of hippocampal-related memory processes to addiction, retigabine may have therapeutic potential.
Pharmacological Reports | 2010
Bogusława Pietrzak; Elżbieta Czarnecka
Oxcarbazepine is a representative molecule for a new class of anticonvulsant drugs that can treat alcohol dependence in addition to other disorders. Interestingly, the central mechanism of action in oxcarbazepine is very similar to ethanol, suggesting that these two agents may interact and cause enhanced effects in the central nervous system. In this study, we used a pharmaco-EEG method to examine the influence of oxcarbazepine on the effect of ethanol on the EEG of rabbits (midbrain reticular formation, hippocampus, frontal cortex). Oxcarbazepine was administered po as a single dose (20 mg/kg or 80 mg/kg) or repeatedly at a dose of 40 mg/kg/day for 14 days. Ethanol was injected iv at a dose of 0.8 g/kg 60 min after the administration of oxcarbazepine. Ethanol caused an increase in the low frequencies (0.5-4 Hz) in the recordings, and it caused a marked decrease in higher frequencies (13-30 Hz and 30-45 Hz). Oxcarbazepine altered the EEG pattern in rabbits; this interaction was dependent on the dose of the drug and whether it was administered as a single dose or as multiple doses. Oxcarbazepine administered at a lower dose had a synergistic effect with ethanol in the frontal cortex and midbrain reticular formation, and a similar effect was observed in the hippocampus at a higher dose. Changes in EEG recordings after the administration of oxcarbazepine alone were more pronounced after multiple administrations. The drug decreased the sensitivity of the hippocampus to ethanol, an observation that may be important for the treatment of alcohol addiction.
Neuroscience Letters | 2016
Ewa Zwierzyńska; Dariusz Andrzejczak; Bogusława Pietrzak
New antiepileptic drugs have been investigated for their potential role in the treatment of alcohol dependence. One of these drugs is retigabine and this study examines the effect of retigabine co-administered with ethanol on the development of alcohol dependence and the course of acute withdrawal syndrome. A pharmaco-EEG method was used to examine this impact in selected brain structures of rabbits (midbrain reticular formation, hippocampus and frontal cortex). Retigabine was administered p.o. at a dose of 5mg/kg/day with ethanol ad libitum for 6 weeks and then alone for 2 weeks during an abstinence period. Changes in bioelectric activity, which demonstrated the inhibitory effect of alcohol on the brain structures, were already visible after 2 weeks of ethanol administration. In the abstinence period, changes were of a different nature and significant neuronal hyperactivity was observed, particularly in the midbrain reticular formation and the hippocampus. This findings reveal that retigabine decreased ethanol-induced changes during both alcohol administration and abstinence periods. In particular, the modulatory effect of retigabine on the hippocampus may be a significant element of its mechanism of action in alcohol dependence therapy.
Postepy Higieny I Medycyny Doswiadczalnej | 2015
Bogusława Pietrzak; Ewelina Wlaźlak; Ewa Zwierzyńska
Estrogens are widely used in hormone replacement therapy, gynecology, urogynecology and rarely in dermatology. Non-therapeutic use of estrogens is very widespread. Estrogens are used as contraceptives, which cause a lot of serious side effects. A common clinical problem is skin hyperpigmentation (melasma), occurring mainly in women who take contraceptives with high doses of estrogens. But low doses of estrogens may also cause skin side effects. The mechanism of melasma development is very complicated and not fully understood. It is very likely that UV radiation and genetic background can affect melasma development. Effective therapy should lead to prevention or alleviation of relapses. Treatment should also reduce the area of lesions and improve the appearance of skin. There is no effective and universal pattern of treatment, in which only one substance or method is used. A combination of different methods is used to optimize the therapy. An important role is attributed to prevention, especially protection from UV radiation.
Alcohol and Alcoholism | 2014
Bogusława Pietrzak; Ewa Zwierzyńska; Agata Krupa
AIMS Recent research suggests a potential role for a new generation of anticonvulsant drugs, including zonisamide, in the treatment of alcohol dependence. Some elements of the central mechanism of action that zonisamide has in common with ethanol, give rise to the question of whether there is an interaction between these two agents and whether there is any risk associated with the enhanced depressive effect of these agents on the central nervous system. METHODS This study uses a pharmaco-EEG method to examine the interaction of ethanol with zonisamide. The influence of zonisamide on the effect of ethanol on EEG of rabbits (midbrain reticular formation, hippocampus, frontal cortex) was determined. Zonisamide was administered p.o. as a single dose (20 or 60 mg/kg) or repeatedly at a dose of 30 mg/kg/day for 14 days. Ethanol was injected i.v. at a dose of 0.8 g/kg 180 min after the administration of zonisamide. RESULTS Ethanol caused an increase in the low frequencies (0.5-4 Hz) in the recording, as well as a marked decrease in the higher frequencies (13-30 and 30-45 Hz). Changes in the EEG recordings after zonisamide alone were more significant compared with these after repeated doses. In the hippocampus after single dose of drug the proportion of the low frequency (0.5-4 Hz) increased, whereas the proportion of high frequencies decreased. Combined administration of ethanol and zonisamide (60 mg/kg) resulted in a markedly synergistic effect in the examined structures. A beneficial effect of repeatedly administered zonisamide on ethanol-induced EEG changes was observed, especially in the hippocampus. CONCLUSION Zonisamide in repeated doses decreases the sensitivity of the hippocampus to ethanol, an observation that may be important in the treatment of alcohol addiction.
Epilepsy & Behavior | 2017
Ewa Zwierzyńska; Agata Krupa-Burtnik; Bogusława Pietrzak
OBJECTIVE Retigabine is a novel antiepileptic drug with a unique and complex mechanism of action which allows its use in many diseases associated with impaired neuronal activity. This study sought to examine the impact of retigabine on two types of memory in rats. METHODS Adult male Wistar rats were used to assess the effect of retigabine, administered p.o. as single (10mg/kg or 20mg/kg) or repeated doses, on spatial memory with the Morris water maze test (MWM) and emotional memory, associated with fear, with the passive avoidance test (PA). RESULTS Retigabine administered at a high single dose transiently impairs learning processes in rats. In the MWM, these changes were delayed in time and of a lesser degree when retigabine was given at low single dose. Additionally, the drug administered repeatedly for 2weeks slowed learning processes in the MWM, but this effect occurred only after 1week of administration in the PA. CONCLUSION These findings indicate that retigabine may affect memory and learning processes, especially in the first phase of administration.
Alcoholism and Drug Addiction | 2017
Agnieszka Wiesner; Ewa Zwierzyńska; Bogusława Pietrzak
Alcohol dependence (AD) is a chronic and recurrent disease that is a major social and clinical problem. The Food and Drug Administration (FDA) has approved a few drugs for AD treatment like disulfiram, naltrexone and acamprosate. Their efficacy is limited and depends on many additional factors. Also therefore, new methods of therapy are still being sought. Currently, research is focused on a new generation of antiepileptic drugs that could improve the efficiency of AD treatment thanks to their multidirectional mechanism of action associated with neurotransmission systems involved in the pathogenesis of addiction. Topiramate is the most widely studied drug in this area. The results of preclinical studies showed that the drug reduces the intake of ethanol and alleviates symptoms of withdrawal syndrome in animals. The results of clinical observations in patients with AD confirmed the efStreszczenie
Alcohol and Alcoholism | 2017
Agata Krupa-Burtnik; Ewa Zwierzyńska; Anna Kordala; Bogusława Pietrzak
Aims Zonisamide is a new anti-epileptic drug whose mechanism of action is associated with neurotransmission systems also involved in the pathogenesis of addiction. Recently, the role of memory processes and the hippocampus (Hp) is underlined in dependence. In our previous study, we determined that zonisamide decreases changes in hippocampal bioelectric activity induced by a single dose of ethanol. Methods This study uses a pharmaco-EEG method to examine the impact of zonisamide on the development and course of alcohol dependence in rabbits. Quantitative changes in EEG were observed in the midbrain reticular formation, Hp and frontal cortex. Zonisamide was administered p.o. once a day at dose of 30 mg/kg/day during the entire experiment. Solutions with increasing concentrations of ethanol were administered for 6 weeks, followed by a 2-week period of abstinence. Results The long-term administration of ethanol caused characteristic changes in rabbit EEG recordings, which were associated with a shift toward lower frequencies resulting in a depressive effect on the bioelectric activity of selected brain structures. Co-administration of zonisamide and ethanol caused a reduction of ethanol-induced alterations. Changes in EEG recordings were different during period of abstinence and were associated with potent shift toward the high frequencies. Zonisamide significantly decreased encephalographic features of neuronal hyperactivity when administered during the abstinence. Conclusion Zonisamide decreases ethanol- and abstinence-induced changes in the EEG recordings. These effects may be a significant part of drugs mechanism of action in alcohol addiction therapy. Short Summary A pharmaco-EEG method was used to determine the influence of a new anti-epileptic drug zonisamide on the development and course of alcohol dependence in rabbits. The drug co-administered with ethanol decreased alcohol-induced changes in selected brain structures. Zonisamide also decreases abstinence-induced changes in the EEG recordings.
Polish Journal of Food and Nutrition Sciences | 2014
Anna Kordala; Bogusława Pietrzak
Abstract Calorie restriction is the only intervention proved to prolong both average and maximum lifespan in yeast, worms, fish, rodents and possibly primates. Not only does the regimen prolong life, but it also reduces the incident of numerous age-related diseases like diabetes, atherosclerosis or cancer and slows down ageing. Mechanisms by which that is thought to occur have not yet been elucidated, but they probably involve reactive oxygen species signaling, insulin growth factor and transcriptional factors. Here, special emphasis is given to SIRT1 - silent information regulator. There is sound evidence showing that SIRT1 is a key player in mediating physiological response to calorie restriction and that its overexpression is correlated with extended lifespan. The possible mechanism leading to its elevated levels is high NAD/NADH ratio, observed in Sir2 in yeast. SIRT1 increases glucose production, enhances fat mobilization, stimulates angiogenesis, prevents neuronal degeneration and rises insulin sensitivity. Therefore, it seems to be a very beneficial factor activated by such a simple intervention that is calorie restriction.
Alcoholism and Drug Addiction | 2014
Ewa Zwierzyńska; Bogusława Pietrzak
Abstract Addiction is a chronic disease involving system of brain reward, motivation and memory. Its development is associated with different neurotransmitter systems. Of vital significance is dopaminergic transmission in the mesolimbic system, which is under modulatory influence of excitatory and inhibitory neurotransmitters. In this article, we discuss different concepts and hypothesis that attempt to explain mechanisms associated with addiction. According to the incentive-sensitisation view, addiction is a result of progressive neuroadaptation and is associated with sensitisation of brain systems that mediate a reward (“wanting”) but do not mediate the pleasurable effects of drugs (“liking”). In other theories, addiction is related to learning, memory processes and formation of secondary reinforcements. Recent data suggest that the hippocampus plays an important role in the pathogenesis of addiction. This brain structure is associated with memory processes, the mechanism of positive reinforcement and it also effects control of appetitive behaviour. The hippocampus is one of a few brain regions that reveals a high concentration of ghrelin receptors. Ghrelin is a hormone that enhances hippocampal synaptic plasticity and is associated with motivational and reward behaviour. The paper also presents the significance of hippocampal endocannabinoids and adverse effect of long-term psychoactive drug use on neurogenesis processes in the hippocampus. Modulatory effect on the function of this structure may impair memory processes, which are important in the mechanism of addiction.